40 Stocks Moving In Monday's Mid-Day Session

Gainers

• Mirum Pharmaceuticals, Inc. MIRM shares jumped 164.4% to $21.66 after the company announced it completed a successful pre-NDA meeting with the FDA for its Maralixibat.
• Axsome Therapeutics, Inc. AXSM gained 61.4% to $75.50 after the company's phase 3 study to treat major depressive disorder met its primary endpoint.
• SIFCO Industries, Inc. SIF shares rose 32% to $3.5620 following Q4 results. SIFCO Industries posted Q4 earnings of $0.43 per share, versus a year-ago loss of $0.49 per share.
• Relmada Therapeutics, Inc. RLMD climbed 24.6% to $42.55. Guggenheim initiated coverage on Relmada Therapeutics with a Buy rating and a $64 price target.
• La Jolla Pharmaceutical Company LJPC gained 20.9% to $4.05.
• BioXcel Therapeutics, Inc. BTAI gained 14.4% to $7.76.
• Camber Energy Inc CEI shares rose 14.1% to $2.03.
• Titan International, Inc. TWI gained 12.7% to $3.54.
• BioNTech SE BNTX shares rose 12.5% to $36.51 after gaining 8.75% on Friday.
• Rayonier Advanced Materials Inc. RYAM jumped 12.2% to $4.4550.
• The Goldfield Corporation GV gained 11.7% to $3.05 after the company won 2 Florida contracts expected to add $35 million of revenue in 2020 and $15 million of revenue in 2021.
• ProQR Therapeutics N.V. PRQR shares rose 11.7% to $10.98.
• Amneal Pharmaceuticals, Inc. AMRX surged 11.2% to $5.30 on seemingly no company-specific news. The stock is trading on higher-than-average volume.
• Intrexon Corporation XON rose 11.1% to $6.32.
• PhaseBio Pharmaceuticals, Inc. PHAS gained 10.7% to $3.73.
• Perion Network Ltd. PERI gained 10.5% to $5.83.
• SMART Global Holdings, Inc. SGH surged 10% to $35.10. Deutsche Bank maintained SMART Global with a Buy and raised the price target from $30 to $34.
• Pyxus International, Inc. PYX gained 9.6% to $6.40.
• Oasis Petroleum Inc. OAS surged 9.1% to $2.9246.
• Granite Construction Incorporated GVA gained 8.8% to $28.52.
• Axovant Gene Therapies Ltd. AXGT surged 8% to $5.97.
• Salarius Pharmaceuticals Inc SLRX rose 7% to $4.48 after the company received FDA Fast Track designation for lead drug candidate, Seclidemstat, in relapsed or refractory ewing sarcoma.
• British American Tobacco p.l.c. BTI rose 4.1% to $42.35 after Bank of America raised its rating of the stock from Underperform to Buy.

Check out these big penny stock gainers and losers

Losers

• Wave Life Sciences Ltd. WVE shares tumbled 51.9% to $18.07 after the company announced it would discontinue the development of its Suvodirsen for Duchenne muscular dystrophy.
• Gossamer Bio, Inc. GOSS dropped 35.9% to $16.26 after drug company Novartis discontinued development of a treatment that shares characteristics with Gossamer's lead candidate.
• Communications Systems, Inc. JCS shares declined 20.8% to $7.52.
• NantKwest, Inc. NK shares declined 18.6% to $2.3446.
• Tutor Perini Corporation TPC fell 17.4% to $13.00.
• LMP Automotive Holdings, Inc. LMPX fell 15.4% to $24.28 after climbing 28.94% on Friday.
• PG&E Corporation PCG fell 14.6% to $9.60 after California Governor Gavin Newsom rejected the company's bankruptcy reorganization proposal.
• Avadel Pharmaceuticals plc AVDL dipped 10.3% to $6.46. Avadel Pharma recieved the FDA approval for Nouress.
• BioLineRx Ltd. BLRX shares dropped 9.6% to $2.16.
• REV Group, Inc. REVG dipped 9.1% to $11.75. Morgan Stanley downgraded REV Group from Equal-Weight to Underweight and announced an $11 price target.
• Aprea Therapeutics, Inc. APRE shares declined 9% to $33.57.
• Jounce Therapeutics, Inc. JNCE fell 8.6% to $8.42.
• Athenex, Inc. ATNX fell 8.6% to $13.30. Athenex expanded its strategic partnership with Guangzhou Xiangxue Pharmaceutical through a licensing agreement.
• Avalon GloboCare Corp. AVCO dropped 8% to $2.08.
• Puma Biotechnology, Inc. PBYI fell 7.8% to $8.63.
• Electrameccanica Vehicles Corp. SOLO shares declined 7.5% to $2.09.
• International Flavors & Fragrances Inc. IFF fell 7.4% to $124.09 after the company reported plans to merge with DuPont's nutrition & biosciences business.